Health Products

Fibristal 5MG (2020-09-24)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II

Summary

Product

Fibristal 5MG

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDIN, NPN, DIN-HIMDosage formStrength
T7B236A
Recalling Firm
Allergan Inc.
500 Enterprise Blvd. Suite 500
Markham
L65 0B5
Ontario
CANADA
Marketing Authorization Holder
Allergan Inc.
500 Enterprise Blvd. Suite 500
Markham
L65 0B5
Ontario
CANADA
Fibristal 5MGDIN 02408163TabletUlipristal Acetate 5MG

Reason

During post-market experience, rare cases of liver injury, including cases of serious liver impairment requiring liver transplantation, were reported in patients using ulipristal acetate 5mg.

Depth of distribution

Wholesalers, Healthcare establishments, Physicians
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime